# A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

> **NCT07181343** · PHASE1 · COMPLETED · sponsor: **Hansoh BioMedical R&D Company** · enrollment: 18 (actual)

## Conditions studied

- Psoriasis (PsO)

## Interventions

- **DRUG:** HS-10374 tablets
- **DRUG:** Drospirenone and Ethinyl Estradiol tablets

## Key facts

- **NCT ID:** NCT07181343
- **Lead sponsor:** Hansoh BioMedical R&D Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-28
- **Primary completion:** 2025-06-17
- **Final completion:** 2025-08-19
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07181343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07181343, "A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07181343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*